Curaleaf Holdings (CSE: CURA) is looking to be the second US-based cannabis operator to list on the Toronto Stock Exchange. The firm announced this morning that it has formally filed an application for listing.
“I believe uplisting to the TSX will provide greater access to a broader set of global institutional investors, offer custody solutions backed by U.S. financial institutions, reduce volatility in our stock by having dedicated market makers, and make Curaleaf available for inclusion into indexes such as TSX and MSCI, all to the benefit of our stakeholders,” commented executive chairman Boris Jordan on the filing.
The listing however remains subject to review and approval of the TSX, and is contingent on all listing and regulatory requirements being met. Curaleaf in early October to that end completed a marketed offering of its subordinate voting shares to the tune of $16.2 million, which was conducted to meet a condition required for the listing.
If approved, Curaleaf would follow TerrAscend Corp (CSE: TER), who in July became the first US-operator to directly listing on the TSX. That same month, Curaleaf began a reorganization of its US assets in an effort to seek a TSX listing of its own.
Curaleaf Holdings last traded at $5.77 on the CSE.
Information for this story was found via Sedar and the sources mentioned. The author has no securities or affiliations related to this organization. Views expressed within are solely that of the author. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
